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Abstract
The field of medical microbiology has prospered for decades, finding treatments and cures for a
multitude of bacterial infections. While success has been found in certain areas, challenges have
arisen along the way. One of those challenges being the group of bacteria known as ESKAPE. The
ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) have developed
their multidrug resistance through adaptation to excessive drug use or prescription, unnecessary
antimicrobial utilization, and substandard pharmaceuticals. They are the major cause of
nosocomial infections throughout the world. With the ever-growing concern of antibiotic
resistance in treating bacterial infections, search for novel alternative therapy is essential. Green
tea polyphenols in herbal plant Camellia sinensis has been found to have antioxidant, antibacterial,
and anti-inflammatory properties. Epigallocatechin gallate (EGCG) is the main polyphenol
responsible for these characteristics. Unfortunately, EGCG is not stable in its natural form and so
epigallocatechin-3-gallate-sterate (EGCG-S) and palmitoyl-epigallocatechin-3-gallate (P-EGCG)
were created to stabilize the polyphenol. EGCG-S was used to study its inhibitory effect on
ESKAPE bacteria. Colony forming unit assay (CFU) was used to determine the % of inhibition
and log reduction of EGCG-S treatment. Congo red qualitative assay and Crystal Violet
quantitative assay were used to study its effect on bacterial biofilm formation. The organic
formulation cF1 and cF2 containing palmitoyl-epigallocatechin-3-gallate (P-EGCG) was also used
to evaluate their antibacterial effect. LIVE/DEAD Bactlight TM Bacterial Viability test was
conducted to determine the efficiency of the treatments via fluorescent microscope. Studies
conducted showed that EGCG-S have a positive effect on the inhibition of these bacteria and their
biofilm. The formulations can efficiently inhibit the growth of the bacteria, cF1 and cF2 can inhibit
the growth of ESKAPE at nearly a 100%. EGCG-S has potential to be an alternative treatment
method that can work alone or in combination with antibiotics. Formulations cF1 and cF2 can be
effective antibacterial agents against ESKAPE bacteria
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Introduction
In 1928, Alexander Fleming discovered the first ever antibiotic, penicillin. Since then, the
field of medical microbiology has vastly improved, creating a multitude of treatments for
infections, illnesses, and diseases. As antibiotics became more common, evolution took its
course, and microorganisms began to build a resistance to them. An abundant over reliance and
usage of antibiotics has led to antibiotic resistant bacteria being a prominent issue in the medical
field (Fair, et al., 2014). This overuse of antibiotics causes the drugs to slowly become less and
less effective. When bacteria can withstand multiple types of antibiotics, they become what is
known as a superbug (Cahill, et al., 2022). A group of multi-drug resistant bacteria known as the
acronym ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter aerogenes) have become a
major threat to public health. The threat of ESKAPE bacteria comes from their multiple
mechanisms of drug resistance. These categories include drug alteration/inactivation, changes in
cell permeability, modification of drug binding sites/targets, horizontal gene transfer, and the
formation of biofilms as shown in Figure 1 (Santajit, et al., 2016).

Figure 1: Diagram of multiple antibiotic-resistant mechanisms of ESKAPE (Saha, Sarkar 2021)
Beta-lactamase is one of the more prominent enzymes in ESKAPE bacteria that allow the
ability to hydrolyze beta-lactam rings, inhibiting the usage of penicillin’s, carbapenems, and
other antibiotics of this category. This enzyme is categorized into two systems: the Ambler
scheme and the Bush-Jacoby-Medeiros system are the most important system, that categorizes
beta-lactamases produced by Gram-negative bacteria (Santajit, et al., 2016). Bacteria, that are
categorized in the latter include metallo-beta-lactamases, require Zn2+ as a cofactor, causing
them to have resistance to all beta-lactams. The most common form of metallo-beta-lactamases
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have been found in Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter
baumannii.
ESKAPE bacteria can alter their target site usually through mutations. S. aureus encodes
a protein known as penicillin-binding protein, an enzyme that is attached to the membrane of the
cell wall and aids with development of it. Penicillin-binding protein 2a is the most common
protein in methicillin-resistant-Staphylococcus aureus. This protein has a lower affinity for betalactam antibiotics allowing for survival against this family of treatment. (Santajit, et al., 2016).
This form of resistance is found in Gram-positive microorganisms and can be treated with
glycopeptides but E. faecium can further increase its resistance by altering the peptidoglycan
target.
Should an antibiotic penetrate the cell wall of a microorganism, ESKAPE bacteria can
reduce accumulation and efficiency by decreasing the amount of protein channels and by the
usage of an efflux pump. P. aeruginosa and A. baumannii use a system known as porins, a type
of protein that allows for hydrophilic material to pass through. The reduction of their outer
membrane protein allows for them to become semi-resistant to drugs. (Santajit, et al., 2016).
Efflux pumps function as an exporter that expel substance from within back outside of the cell.
This results in the buildup of antibiotics never being high enough to inhibit the bacteria. Efflux
pumps can pump a variety of supplements with the most common efflux pump being the
polyselective efflux pump. This pump can expel not only antibiotics, but detergents and biocides
as well, both being used in the medical field (Santajit, et al., 2016). P. aeruginosa and A.
baumannii have the unique characteristic of having both an efflux pump as well as a porin,
allowing for resistance to a multitude of antibiotics for greater efficiency.
One of the more notable resistance mechanisms in these pathogenic bacteria is the
formation of a thin bacterial colony layer that lives on surfaces, known as biofilms. Biofilms are
a self-made extracellular polymeric substance that contain amyloid fibers and other biopolymers,
which helps protect them from outside sources. Once a biofilm is formed, it has the potential to
develop 1000x more antibiotic resistance compared to regular growth of the microorganism (Lin,
et al., 2018). The development of biofilms are divided into five main stages: (i) the initial
attachment phase where the bacteria attaches to a surface non-specifically; (ii) bacterial cells
interacting with the surface with bacterial adhesins; (ii) production of the extracellular polymeric
substances; (iv) bacterial cells release signaling molecules to sense other molecules for allow for
formation of microcolony, known as the biofilm maturation phase; (v) detachment phase, the
bacterial cells leave the biofilm and return to a planktonic growth (Muhammad, et al., 2020). The
formation of biofilms is not necessary for antibiotic resistance; it does greatly contribute to a
microorganism’s resilience. The conditions that allow the growth of biofilms already make for
difficulty of antibiotic attenuation. The bacteria extracted from biofilms and grown back in a
broth revert to their normal susceptibility showing that biofilm resistance is a phenotypic trait
compared to a genotypic trait (Santajit, et al., 2016). Out of the six ESKAPE bacteria only four
efficiently form biofilms: S. aureus, K. pneumoniae, A. baumannii, and P. aeruginosa (Santajit,
et al., 2016).
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Found from the plant Camellia sinensis, green tea has been shown to have health benefits
such as antioxidant, anti-inflammatory, and anti-bacterial properties (Melok, A., et al., 2018;
Chan, Tie, Soh & Law 2011, Reygaert 2014). It is also reported that EGCG and EGCG-S can
enhance the antimicrobial activity of many antibiotics (Haghjoo B, et al., 2013; Yussof A., et al.,
2019). In addition, EGCG and EGCG-S can effectively work on the endospores of many
bacteria. (Ali B., et al., 2017; Chu T et al., 2020; Chu T, et al., 2019)
Within green tea are four catechins: epicatechin (EC), epicatechin-3-gallate (ECG),
epigallocatechin (EGC), and epigallocatechin-3-gallate with EGCG being the majority of
catechins in green tea at 59% (EGCG) (Reygaert, et al., 2016). Catechins within green tea have
been shown to induce the production of cytokines that can then cause damage to bacterial cell
membranes, inhibition of enzymes and inhibition of efflux pump activity (Noormandi, et al.,
2014). The main concern with EGCG is its chemical structure not being stable, making its
availability a challenge (Widyaningr, et al., 2015). To solve this concern, EGCG has been
modified to be a chemically stable compound known as EGCG-Stearate (EGCG-S) and
palmitoyl-epigallocatechin-3-gallate (P-EGCG). These esterified forms of EGCG contain a
carbon chain to give it a fatty acid, causing the polyphenol to be lipophilic and raising
absorption. Despite the health benefits of EGCG, its mechanisms were not well known with it
believed that its transduction pathways are what make it such an effective catechin (Steinmann,
et al., 2013).

Figure 2: Molecular Structure of EC, ECG, EGC, and EGCG (Hassan and Nihal, 2008)
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Figure 3: Molecular Structure of P-EGCG drawn in Biovia Draw

Figure 4: Molecular Structure of EGCG-S drawn in Biovia Draw
Studies of fluorescence microscopy and scanning electron microscopy have shown that
EGCG-S works on the integrity of the cell surface, giving implications that its mechanisms are
identical to that of EGCG, damaging either the cell wall, cell membrane, or disrupting the
interaction of polysaccharides (Melok, et al., 2018). The antibacterial properties of EGCG
consist of multiple modes of inhibition that ESKAPE bacteria heavily rely on. EGCG can inhibit
multiple membrane proteins such as ABC transporter (Oppa), and penicillin-binding-protein5
found in B. subtilis (Nakayama 2015). Catechins can bind with the amino acids of bacterial
proteins via hydrogen bonding to show that EGCG binds to the inner wall of Oppa, preventing
any conformational changes, resulting in inhibition of this function. (Nakayama, et al., 2015).
One of the ESKAPE bacteria, P. aeruginosa, usually resistant to antibiotic aztreonam via betalactamases and carbapenemases, was shown to be susceptible to the restoration of this treatment
from EGCG (Betts, et al., 2019). Adding ascorbic acid prevents oxidation of EGCG while
sucrose enhances absorption. Topical application of EGCG was found to have the greatest effect
while restoring aztreonam to levels below the European committee on antimicrobial
susceptibility testing (EUCAST) breakpoint (Betts, et al., 2019).
Alongside the lack of understanding EGCG’s mode of mechanism, its ability to inhibit
biofilms is also not well studied. Polyphenols of green tea have been studied on bacteria such as
Escherichia coli, Staphylococcus aureus, Enterobacter faecalis, and more. (Slobodníková, et al.,
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2016). Escherichia coli has the ability to create a special version of biofilm that consists of curli
amyloid fibers, a structure that allows for extra protection from environmental factors (Serra, et
al., 2016). These biofilms are further enforced by cellulose filaments that help determine the
shape and microcolony of biofilms (Serra, et al., 2016). Within these biofilms EGCG can inhibit
the production of these amyloid fibers by two main mechanisms, (i) interfering with the
assembly of curli subunits, (ii) activation of sigma factor E, a response factor that envelops stress
in E. coli, reducing overall expression in the bacteria (Serra, et al., 2016). Recently, EGCG-S has
reported an efficient anti biofilm agent against many Gram-positive and Gram-negative bacteria
Studies in recent years have shown EGCG to be a potential solution to the treatment of
ESKAPE bacteria. EGCG has a multitude of anti-bacterial traits making EGCG-S an ideal
antibiotic treatment to build upon this. Another stable form of EGCG known as palmitoylepigallocatechin-3-gallate (P-EGCG) has been created to observe and see if this form of the
catechin will also yield antibacterial properties. Formulations known as cF1 and cF2 will be used
with cF1 being in a gel form and cF2 being liquid. These epigallocatechin-palmitate-based
formulations will be tested as candidates for treatments against ESKAPE. All ESKAPE bacteria
will be used in this study (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter aerogenes),
with EGCG-S, cF1 and cF2 being the main forms of treatment. Antibiotics erythromycin (Gramnegative bacteria) and tetracycline (Gram-positive bacteria) (Shinde, et al., 2021) will also be
used for their commonality in the industry as well as their poor inhibition on multi-drug resistant
ESKAPE.
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Objective of Study
•

Determine the inhibition efficiency of EGCG-S and P-EGCG compared to formulated PEGCG treatments (cF1, cF2) on ESKAPE bacteria

•

Determine the inhibition efficiency of EGCG-S and P-EGCG compared to formulated PEGCG treatments (cF1, cF2) on the production of biofilms of ESKAPE bacteria

•

Observe the effect of treated (with formulation cF2) and untreated ESKAPE bacteria via
a fluorescence microscopy

•

Bioinformatics analysis of EGCG-S on antibiotic resistant mechanisms
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Materials and Methods
Bacterial Cultures
The bacterial cultures used for this study are the following: Gram-positive bacteria Enterococcus
faecium, Staphylococcus aureus, and Gram-negative bacteria: Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter aerogenes. Enterococcus
faecium was cultured on brain heart infusion plates, while all other microorganisms were
maintained on either trypticase soy agar plates or nutrient agar plates. Fresh overnight cultures
were prepared for experiments accordingly with tryptic soy broth or nutrient broth. A cotton
swab was used to collect the bacteria and then placed into the 1mL tryptic soy broth. The test
tube was then vortexed for 30 seconds. The overnight cultures were then placed in a shaker
incubated at 37℃, 250 rpm for 24 hours and observed to see if any growth occurred. If no
growth was present after 24 hours, the cultures were incubated for an additional 24 hours. Fresh
stock plates were made from overnight cultures. The stock cultures were streaked onto nutrient
agar plates via a disposable sterile loop or sterile swab. The sterile swab or loop was discarded to
prevent any contamination. The newly made plates were inverted and incubated overnight at
37℃ for 24 hours. The plates were taken out and placed in a 4℃ refrigerator as stocks for future
overnight cultures.

Bacterial Isolation
Initial stock culture plates underwent discontinuous streaks to ensure single colony isolation.
Plates were streaked as seen in figure 5. The discontinuous plates grew 37℃ for 24 hours. The
single colony was then used to create an overnight culture as well as a stock plate to ensure pure
cultures.

Figure 5: Image of discontinuous streak method (Lee et al., 2019)

Cytological staining techniques:
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Gram stains were performed to ensure the correct microorganisms were used and that there was
no contamination. Samples were obtained from fresh overnight cultures. With a sterile loop, the
samples were smeared onto a slide that was then set to air dry and heat fixed after fully drying.
The slide was covered in crystal violet for 20 seconds and rinsed with distilled water for 2
seconds. Gram’s iodine was applied to the slide for 1 minute and rinsed with 95% ethanol
(Gram’s decolorizer) for 10 seconds. The slide was then rinsed with distilled water and counter
stained for 1 minute with safranin. The slide was blot dried and a cover slip was placed over the
slide. The slide was observed at 1000x total magnification under oil immersion (Lee et al, 2015).

Serial dilutions
Dilutions were conducted at 10-2, 10-4, and 10-6 to determine which concentration was best for
future studies. 100 μL of overnight culture was transferred into an Eppendorf tube. From there,
10 μL was taken out of that Eppendorf tube and placed into another Eppendorf tube with 990 μL
distilled water, giving a 1:100 ratio. The Eppendorf solution containing the 10-2 solution has 10
μL transferred to another Eppendorf tube of 990 μL distilled water. This was then repeated once
more giving all the desired dilutions. All Eppendorf tubes were vortexed for 20 seconds,
followed by having 100 μL be pipetted and streaked onto individual nutrient agar plates. All
plates were inverted at 37℃ for 24 hours. Plates were counted following incubation period with
a countable range being 150-300 colonies.

1) Evaluate the effect of P-EGCG and EGCG-S on the growth of bacteria
A) Treatment for 1 hour
Overnight cultures were prepared of all bacteria accordingly. Take 90 μL of culture and 10 μL of
tryptic soy broth (TSB) and mix in an Eppendorf tube as a control. Repeat this process once
more for an additional plate. Combine 90 μL of overnight culture and 10 μL of 2.5 mg/ml
epigallocatechin gallate stearate (EGCG-S) (10x) in an Eppendorf tube and vortex for 30 seconds
and have the mixture sit for one hour giving a final concentration of 250 μg/mL. This process
was repeated for P-EGCG (10x) as well as 10% Clorox mixture.
B) CFU assay
Two serial dilutions of the EGCG-S mixture were made based on what the best dilutions were
from the stock plates. (10-4 and 10-6). Overnight cultures mixed with EGCG-S have 10 μL
pipetted and mixed with 990 μL of DI H2O to create a 10-2 mixture. This process was repeated
two additional times to make the 10-4-, and 10-6 dilutions, respectively. The 10-4 and 10-6
dilutions will have 100 μL pipetted onto two trypticase soy agar plates. This process was
repeated with the P-EGCG mixture. The dilutions of 10-4 and 10-6 were again prepared. The 10-4
and 10-6 dilutions have 100 μL pipetted onto two TSB plates. This process was repeated but with
10% Clorox and making serial dilutions of 10-2 and 10-4. Pipette 100 μL of the 10-2 and 10-4
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dilutions onto two TSB plates, respectively. The plates were inverted and incubated overnight at
37℃ for 24 hours.
C) Calculations
All growth of ESKAPE bacteria had log reductions calculated. Experiments that used
formulations cF1 and cF2 had the standard deviation calculated as well. Standard deviations
were found in Excel using the command “=STDEV.S” of the respective numbers. Error bars
were added to all graphs to account for this. Log reductions were calculated with the formula
“log10(A/B)” where A is the number of bacterial cells prior to treatment and B is the number of
viable bacterial cells after treatment.

2) Evaluate the effect of cF1/cF2 on the growth of bacteria
A) Treatment for 1 hour
Overnight cultures of all bacteria were prepared accordingly. Take 90 μL of culture and 10 μL of
tryptic soy broth and mix in an Eppendorf tube as a control. This process was repeated once
more for an additional plate. Combine 90 μL of overnight culture and 10 μL of cF1 in an
Eppendorf tube and vortex for 30 seconds and have the mixture sit for one hour. This process
was repeated for cF2 as well. All treatments were plated out on nutrient agar plates
B) CFU assay
Overnight cultures were prepared of ESKAPE bacteria. Take 10 μL of culture and 90 μL of
tryptic soy broth and mix in an Eppendorf tube. 900 μL of PBS was added to the mixture as a
control. Repeat this process once more for an additional plate. Aliquot 10 μL of overnight culture
and 90 μL of cF1 in an Eppendorf tube containing 900 μL of PBS. Vortex for 30 seconds and
have the mixture sit for one hour. This process was repeated for cF2 as well. All treatments were
plated out on nutrient agar plates.

3) Time course study (suspension method)
Using a 1:10 dilution factor, 10 μL of the overnight cultures were placed in an Eppendorf tube
with 90 μL of cF1 or cF2 for 30 seconds. After the allotted time had passed, 10 μL of the
solution was transferred into an additional Eppendorf tube with 990 μL of phosphate buffer
saline to neutralize the reaction. The mixture was vortexed to ensure homology and a serial
dilution at a 1:10 ratio was conducted giving two final dilutions of the initial PBS solution at 10 -3
and the new dilution of 10-4. Once the proper dilutions have been achieved, 25 μL of the samples
were pipetted into one quadrant of a nutrient agar X plate and then streaked. This process is
repeated for time frames of 2 minutes, 5 minutes, and 10 minutes, each going into their own
remaining portion of the X plate. Once one plate was completed, the steps above were repeated
for treatment cF2 and the control containing tryptic soy broth. The controls were done at their
optimal dilutions that were previously determined. The plates were then inverted and stored in a
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37℃ for 24 hours. The plates were then removed from the incubator, counted, and stored in a
4℃ refrigerator.

cF1 and cF2 study with concentrated cells
When the treatment plates had no growth, concentrated cells with higher density were used to
carry out further experiments. With the prepared overnight culture, 100 μL to 500 μL of the
bacteria was centrifuged at 6,500x rpm for 5 minutes. The supernatant was removed, and the
pellet was resuspended in 10 μL of medium. 10 μL of the concentrated cells were mixed with 90
μL of cF1 or cF2 or 30 seconds. The procedure or dilution was described in section 3-time
course study.

Congo red qualitative biofilm assay
A) Effect of treatment on biofilm formation
24 welled plates were used in this study. In microcentrifuge tubes, prepared overnight cultures 5
μL of bacteria were mixed with 45 μL of different treatments. All mixtures were treated for 5
minutes and 25 μLs were transferred to the corresponding wells. The Congo red plate was then
placed in a small container with a damp paper towel underneath to ensure the plate did not dry
up. Images of the Congo red plate were taken at 24, 48 and 72 hours and checked to see for any
formation of biofilms.
B) Effect of treatment on preformed biofilm
25 μL of overnight cultures were pipetted into wells labeled A, B, C, D, E, F, and G with well H
being a blank. The Congo red plate was placed in a small container with a wet paper towel
underneath it and incubated at 37℃ for 24-48 hours until biofilms were observed. Once biofilms
had formed, 25 μL of different treatments were pipetted into each well, respectively. The plate
was once again placed in a container with a wet towel underneath it and incubated at 37℃.
Images of the plate were taken at 24, 48, and 72 hours post treatment.

Crystal violet assay
Overnight cultures of microorganisms were prepared from stock plates. A 24 well plate was
labeled according to the positive and negative controls as well as the experimental groups. All
positive and negative controls had 700 μL of tryptic soy broth with 0.1% sucrose pipetted into
them while the experimental groups had 600 μL pipetted. The bacterial cultures had 300 μL
transferred into each experimental well except for the blanks. The experimental groups contained
100 μL of various treatments (10x) at various concentrations giving a total volume of 1mL in
each well. A wet paper towel was placed under the plate and then placed in a container and
incubated for 4 days at 37℃. On day 4 the contents of the plates were aspirated and washed with
1x PBS and aspirated. 1mL of 0.1% crystal violet was added to each well and allowed to sit for
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30 minutes. The crystal violet was aspirated followed by a 1x PBS wash that was aspirated and
set to air dry by inverting for overnight. After inverting overnight, 30% acetic acid applied using
a sterile cotton swab to remove the excess dye on the side of the wells. Once the sides of the
wells were clean, 1mL of 30% acetic acid was placed into each well and gently swirled to
attempt to pick up any biofilms that have adhered to the bottom. The 1mL of acetic acid in each
well was transferred to a cuvette for spectrophotometry. The spectrophotometer was turned on,
set to warm up and was set to a wavelength of 595 nm. Once warm, a blank of 1mL 30% acetic
acid was used to calibrate the machine as well as in between readings. If the optical density was
too great and caused an error, the sample was diluted by transferring 500 μL of the solution to
500 μL of acetic acid in a new cuvette. Calculations for readings that required dilutions were
made accordingly. Prior to each reading, the side of the cuvettes were cleaned with Kimwipes.
The percent inhibition was calculated for each treatment using the following

∗

100. Log reductions were calculated as well with the formula Log10 (A/B).

Fluorescent Microscopy
Overnight cultures of all microorganisms were prepared 24 hours before treatment. Treatment
used for this study was cF2 due to it being in a liquid solution compared to cF1 that is in gel
form. LIVE/DEAD® BaclightTM Bacterial Viability Kit (L13152) was used. The kit consists of
two fluorescent dyes, A (Syto®9- Green) and B (Propidium Iodide-Red) that were dissolved in
2.5mL sterile DI H2O individually in dark. Both dye solutions were mixed in the ratio of 60%
reagent A to 40% reagent B due to the propidium iodide-Red being overpowering. The tubes
were always covered in aluminum foil to limit light exposure and stored in the freezer. The
process was carried out in the dark to prevent decaying of fluorescent dye. 10 μL of untreated
culture was transferred onto a slide along with 10 μL of fluorescent dye mixture. Treated slides
had 10 μL of overnight culture mixed with 10 μL of cF2 for 30 seconds. 10 μL of the mixture
was aliquoted onto a slide with 10 μL of fluorescent dye. All slides were left in the dark for 15
minutes to allow the fluorescent dye to mix thoroughly with samples. All samples were observed
under a fluorescent microscope (ZEISS Axio Scope.A1) at 1000x total magnification with
images being taken of each sample. Software used to take images was Zeiss ZEN.

Bioinformatics study
A) Drug modeling
The structure of EGCG-S was drawn as a 2D structure initially with the program BIOVIA Draw
(Bazerra-Silva et al, 2016). Once drawn, the structure was converted into its 3D structure
through Autodock Vina (Trott et al, 2009).
B) 3d Protein Structure Modeling and Trans-membrane Topology Modeling
The sequences and proteins for the bacteria used was obtained from Protein Data Bank (PDB).
These structures and sequences were used to help predict quaternary structures that helped
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determine the binding affinity of EGCG-S to the respective protein. All files were downloaded in
their .pdb format.
C) Binding Energy

Figure 6: Order of sequence for bioinformatics study

Using bioinformatic tools, the binding surface of EGCG-S to protein bacterial surfaces was
simulated. Both amino acid and crystalized structures were obtained from Protein Database.
Enterobacter aerogenes did not have an available protein therefore an identical protein was used.
The 3D structures used helped determine the binding affinity of EGCG-S to the target proteins.
Autodock Vina was used to analyze binding energy as well as the location of the binding site
(Trott et al, 2009).

Mechanism of EGCG-S Binding
A) 3D Structure of EGCG-S
No available structures of EGCG-S were readily available online and so its chemical structure
needed to be drawn as a 2D structure that was then converted to a 3D one. The 2D structure
created in Biovia Draw was uploaded into Vega ZZ. From there, runscript was ran under files,
the Ammp folder was opened and the script “2D to 3D .c” was run. The file was then saved as
.pdb format.
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Figure 7: 2D Structure of EGCG-S in Biodraw

Figure 8: 3D Structure of EGCG-S in VegaZZ
B) Binding Simulation
The protein of choice was initially selected under AutoDockTools. The protein had polar only
hydrogens added with all water molecules removed and a Kollman charge was added to the
protein. The protein was selected as the macromolecule under grid and saved as a .pdbqt file.
The 3D EGCG-S file was opened in AutoDockTools, the option “ligand” was chosen, and the
input was set to “choose” with EGCG-S being selected; the file was saved as a .pdbqt file. The
website CASTP was used to help predict the binding affinity pockets of each protein. The
gridbox option was chosen and aligned to respective regions that matched with CASTP. This
gridbox was outputted and a grid text file was created (figure 9).
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Figure 9: Output of grid dimension files for protein 5FAS
A config text file was saved with all the respective information required to run the AutoDock
Vina script (figure 10).

Figure 10:config file of protein 5FAS (has protein, ligand, grid box location/size, output file
name, exhaustiveness, energy range
Command prompt was opened in administrator mode and the following scripts were run “cd”
(location of the folder containing all files pertaining to the protein and ligand), “(location of
AutoDock Vina program) \vina.exe”. Figures 8 and 9 below show the format of the information
to be filled out. All binding simulations were done through Autodock Vina.

Figure 11:Command prompt information filled out for AutoDock Vina script
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Figure 12:Command Prompt window of script run for protein 5FAS using ligand EGCG-S
C) Interpreting Data of Binding Affinities
Once a binding affinity of -7.0 kcal/mol or stronger was found, the output file was examined in
AutoDockTools with the option: analyze, dockings, open AutoDock Vina result, selecting the
new output file. With the protein file open as well, the binding affinity can be properly observed.
The output file was opened in Biovia Discovery Studio where the protein and ligand could be
observed at a better resolution. 2D images of binding can be found under “receptor-ligand
interactions”, “show 2D diagram”.
Based on previous and current data, EGCG-S is able to bind to surface proteins of bacteria. Two
proteins were observed in all six bacteria: penicillin binding protein, and beta-lactamase.

22

Results
1) Proper dilution factors for ESKAPE bacteria
Serial dilutions of ESKAPE bacteria were carried out and the final two dilutions (either 10-4
and 10-6 and 10-8) were plated. The results are shown in Tables 1 to 6.
A) Enterococcus faecium

Table 1: Colony forming unit table for Enterococcus faecium
Enterococcus faecium was successfully cultured as a stock plate. From the stock plate serial
dilutions were conducted where it was found that 10 -6 was the ideal dilution with a count of 177
colony forming units. From these future experiments can be conducted.

B) Staphylococcus aureus

Table 2: Colony forming unit table for Staphylococcus aureus
Staphylococcus aureus was successfully cultured as a stock plate. From the stock plate serial
dilutions were conducted where it was found that 10 -4 was the ideal dilution with a count of 365
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colony forming units as there was no growth present on a dilution of 10 -6. From this, future
experiments can be conducted.

C) Klebsiella pneumoniae

Table 3: Colony forming unit table for Klebsiella pneumoniae
Klebsiella pneumoniae was cultured into a stock plate. From the stock plate serial dilutions
were conducted where it was found that 10-6 was the ideal dilution with a count of 365 colony
forming units as 10-4 was too numerous to count. From this, future experiments can be
conducted.

D) Acinetobacter baumannii

Table 4: Colony forming unit table for Acinetobacter baumannii
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Acinetobacter baumannii was cultured into a stock plate. From the stock plate serial dilutions
were conducted where it was found that 10-4 was the ideal dilution with a count of 26 colony
forming units as 10-6 had no growth. While growth was present at 10-4, the number of colony
forming units is still notably low. From this, future experiments can be conducted.

E) Pseudomonas aeruginosa

Table 5: Colony forming unit table for Pseudomonas aeruginosa
Pseudomonas aeruginosa was cultured into a stock plate. From the stock plate serial
dilutions were conducted where it was found that 10 -6 was the ideal dilution with a count of 38
colony forming units as 10-4 too great to count. While growth was present at 10-6, the number of
colony forming units is still notably low. Future studies will be conducted with the according
serial dilution that allows for counting of the microorganism.

F) Enterobacter aerogenes

Table 6: Colony forming unit table for Enterobacter aerogenes
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Enterobacter aerogenes was cultured into a stock plate. From the stock plate serial
dilutions were conducted where it was found that 10-6 was the ideal dilution with a count of 192
colony forming units as 10-4 too great to count. Future experiments will be conducted with the
ideal dilution of 10-6.
2) Gram Stain for bacteria
To characterize the properties of the ESKAPE bacteria, the Gram stain was carried out, and
the results are shown in Table 7.

Table 7: Gram stains of all ESKAPE bacteria
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The results indicate that the correct microorganism is present in each bacterial culture,
and they are homogenous in shape and gram stain. The Gram-positive microorganisms are
Enterococcus faecium, and Staphylococcus aureus; they are cocci in shape. The Gram-negative
microorganisms are Klebsiella pneumoniae, Acinetobacter baumannii and Enterobacter
aerogenes; they are all rod shaped

3) EGCG Inhibition
To determine the effectiveness of bacterial inhibition from green tea polyphenols EGCG-S
and P-EGCG, all bacteria were treated for one hour.
A) Enterococcus faecium

Table 8: Inhibition of Enterococcus faecium by EGCG-S and P-EGCG

B) Staphylococcus aureus
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Table 9: Inhibition of Streptococcus aureus by EGCG-S and P-EGCG
C) Klebsiella pneumoniae

Table 10: Inhibition of Klebsiella pneumoniae by EGCG-S & P-EGCG
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D) Acinetobacter baumannii

Table 11: Inhibition of Acinetobacter baumannii by EGCG-S & P-EGCG
E) Pseudomonas aeruginosa

Table 12: Inhibition of Pseudomonas aeruginosa by EGCG-S & P-EGCG
F) Enterobacter aerogenes
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Table 13: Inhibition of Pseudomonas aeruginosa by EGCG-S & P-EGCG

Figure 13: Percent inhibition graph for EGCG-S and P-EGCG of ESKAPE
The inhibition of growth for ESKAPE bacteria was a success overall. All percentages of
inhibition were over 50% except for Staphylococcus aureus. This could be due to the control
plate having too thin of a region of agar (can be seen in Figure 13). Within that region of agar,
there was no growth even though CFU’s were everywhere else on the plate. EGCG-S works best
for Acinetobacter baumannii and Pseudomonas aeruginosa with inhibitions of 99.65398% and
95.01718%, respectively. P-EGCG works best for Klebsiella pneumoniae and Pseudomonas
aeruginosa with inhibitions of 98.684210% and 99.653979%, respectively.
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4) cF1 cF2 Inhibition
To determine the effectiveness of green tea palmitoyl formulations cF1 and cF2 on ESKAPE
bacteria, all bacteria were treated for one hour.
A) Enterococcus faecium

Table 14: cF1 and cF2 treatments of Enterococcus faecium after one hour

B) Staphylococcus aureus

Table 15: cF1 and cF2 treatments of Staphylococcus aureus after one hour
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C) Klebsiella pneumoniae

Table 16: cF1 and cF2 inhibition table of Klebsiella pneumoniae after one hour
D) Acinetobacter baumannii

Table 17: cF1 and cF2 treatments of Acinetobacter baumannii after one hour
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E) Pseudomonas aeruginosa

Table 18: cF1 and cF2 treatments of Pseudomonas aeruginosa

F) Enterobacter aerogenes

Table 19: cF1 and cF2 treatments of Enterobacter aerogenes after one hour
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Figure 14: Percent inhibition bar graph of cF1 and cF2 on ESKAPE after one hour
Formulations cF1 and cF2 are effective inhibitors showing a near 100% inhibition among
all microorganisms. Staphylococcus aureus once again shows some note of resistance to
inhibition compared to the other microorganisms with a percent inhibition of 85.71428%. With
the formulations showing a positive effect on inhibition of growth allows further tests to be
conducted with them. Formulations have a greater inhibition than polyphenols EGCG-S and PEGCG showing that cF1 and cF2 have potential to be treatments against ESKAPE.

5) Time course study
A) Enterococcus faecium

Table 20: Time course study of inhibition due to treatment with cF1 and cF2 on E. faecium
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B) Staphylococcus aureus

Table 21: Time course study of inhibition due to treatment with cF1 and cF2 on S. aureus

C) Klebsiella pneumoniae

Table 22: Time course study of inhibition due to treatment with cF1 and cF2 on K.
pneumoniae
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D) Acinetobacter baumannii

Table 23: Time course study of inhibition due to treatment with cF1 and cF2 on A. baumannii

E) Pseudomonas aeruginosa

Table 24: Time course study of inhibition due to treatment with cF1 and cF2 on P. aeruginosa
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F) Enterobacter aerogenes

Table 25: Time course study of inhibition due to treatment with cF1 and cF2 on E. aerogenes

Results show that the time it takes for the formulations to inhibit growth of ESKAPE
bacteria is less than or equal to 30 seconds. All times have a near 100% inhibition. All bacteria
were successfully inhibited by cF1 and cF2 almost immediately. Results of Staphylococcus
aureus help confirm that CFU inhibition studies did have some sort of error. Previous tests
showed inhibition being notably lower than other ESKAPE bacteria with EGCG-S and P-EGCG
inhibition (22.73973% and 36.16438%) compared to time course study (99.999% and 99.999%).
This result indicates that both cF1 gel form and cF2 liquid form have exceedingly high efficacy
and can work on both Gram (+) and Gram (–) bacteria.

6) Congo red biofilm qualitative assay
Study was conducted to observe the growth and inhibition of biofilms of ESKAPE bacteria.
Treatments consisted of polyphenols EGCG-S and P-EGCG. Two variations of the experiment
were conducted, one having treatments applied before the formation of biofilms and one with
treatments applied after biofilm formations. Plates consisted of 0.1% sucrose to induce formation
of biofilms. An additional study was conducted with the addition of antibiotic treatments
tetracycline and erythromycin, both individually and in combination with green tea polyphenols.
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Figure 15: Negative control of ESKAPE bacteria (Bleach, Blank)

Figure 16: Positive control of ESKAPE bacteria (TSB)

Table 26: Legend for ESKAPE bacteria biofilm formation
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Figure 17: Congo red biofilm formation of Enterococcus faecium 24 and 48 hours
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TSB (control)

(500μg/mL PEGCG)

10% Clorox

(500μg/mL EGCG S)

cF1

PBS

cF2

Blank

Table 27: Legend for ESKAPE preformed biofilm

Figure 18: Congo red preformed biofilm of ESKAPE 24- and 48-hours pre-treatment
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Figure 19: Congo red preformed biofilm of ESKAPE 24- and 48-hours post-treatment
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Figure 20: Combination study: EGCG-S and Tetracycline (Gram positive)/Erythromycin (Gram
negative): Congo red biofilm formation of ESKAPE 24 and 48 hours post inoculation
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Table 28: Combination study: biofilm formation of ESKAPE

Figure 21: Combination study: EGCG-S and Tetracycline (Gram positive)/Erythromycin (Gram
negative) for ESKAPE biofilm formation

Table 29: Combination study: preformed biofilm formation of ESKAPE
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Figure 22: Combination study: EGCG-S and Tetracycline (Gram positive)/Erythromycin (Gram
negative): preformed biofilm formation of ESKAPE 24 and 48 hours
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Figure 23: Combination study: EGCG-S and Tetracycline (Gram positive)/Erythromycin (Gram
negative): preformed biofilm formation of ESKAPE 24 and 48 hours
Results in Figure 15 show that all treatments were able to prevent the formation of
biofilms in ESKAPE bacteria. Growth of control plates confirmed there was no issue with
bacteria. Enterococcus faecium and Enterobacter aerogenes struggled to form biofilms as they
do not excel at biofilm formation. This study can be repeated with a higher sucrose concentration
to help produce biofilms in these bacteria. The lack of biofilms can still be promising as this still
indicates that treatments can still help prevent their formation. Treatments were also able to
reverse the formation of biofilms even after 48 hours. Klebsiella pneumoniae showed the greatest
resistance of all bacteria, staying the darkest color. This is not too surprising considering how
Klebsiella pneumoniae produces thick biofilms. Enterococcus faecium and Enterobacter
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aerogenes still struggled to form biofilms even with the absence of treatment indicating that
these bacteria will have to undergo further forced induction of biofilm formation. Combination
study had the most notable results. Formation of biofilms was prevented with treatment added at
the initial plating. Plates that had treatments added after the formation of biofilms showed the
strongest inhibition characteristics. Those of the most notable biofilm inhibition is the
combination treatment antibiotics with EGCG-S. Plates that had this form of treatment had a
portion of their agar revert to the initial red color. The results show that the combination of
EGCG-S alongside with antibiotics allow for the breakdown of the bacterial cell wall and
inhibition of the microorganism. Green tea polyphenols EGCG-S and P-EGCG successfully
inhibited the formation of biofilms in ESKAPE bacteria. EGCG-S and P-EGCG also worked
with the combination of antibiotics.

7) Crystal Violet assay
Crystal Violet assay was conducted to observe the inhibition of biofilms created by
ESKAPE bacteria in a quantitative manner. Treatments consisted of formulations cF1 and cF2,
EGCG-S, antibiotics erythromycin and tetracycline, as well as combination treatments of EGCGS and antibiotics. Wells were stained with 0.1% Crystal violet and observed at 585nm.

Figure 24: Crystal Violet assay of E. faecium, Figure 25: Crystal Violet assay of A.
S. aureus and K. pneumoniae
baumannii, P. aeruginosa, and E. aerogenes

Table 30: Legend for Crystal Violet assay of Table 31: Legend for Crystal Violet assay of A.
baumannii, P. aeruginosa and E. aerogenes
E. faecium, S. aureus, and K. pneumoniae

Table 32: Biofilm percent inhibition of ESKAPE
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Figure 26: Graph of Crystal Violet assay biofilm inhibition of ESKAPE

Figure 27: Crystal Violet assay of A. baumannii, E. aerogenes, S. aureus and K. pneumoniae

Table 33: Legend for Crystal Violet assay of A. baumannii, E. aerogenes, S. aureus, and K.
pneumoniae
Results for this study were a bit inconclusive. Crystal violet dye ended up sticking to the
bottom of the wells giving false data for biofilm inhibition. The experiment was repeated for S.
aureus, K. pneumoniae, A. baumannii, and E. aerogenes. The second trial yielded better results
but still had many false negatives for biofilm inhibition. This was confirmed from the positive
controls (blank and bleach) showing an enhancement on the growth of biofilms. Certain trends
can still be observed regardless of suboptimal results. In all trials, EGCG-S with antibiotic
treatments yielded greater inhibition than any other treatment. The second trial was for bacteria
that had poor data not capable of being used. This experiment will need to be repeated in the
future with either the dye not sitting as long or a more diluted version to prevent false negative
inhibitions.

47
8) Fluorescent microscopy
This experiment was conducted to qualitatively observe the inhibition of CFU’s for ESKAPE
bacteria. Controls were overnight cultures and treated cells were bacterial cells with cF2.
Fluorescent dye was added for 15 minutes and observed with the aid of Zeiss software. Green
denotes live and red are dead cells.

Control

Treated

A

B

C

D

E

F
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Control

Treated

G

H

I

J

K

L

Table 33: LIVE/DEAD Bactlight Bacterial Viability Assay (A) E. faecium control (B) E.
faecium treated (C) S. aureus control (D) S. aureus treated (E) K. pneumoniae control (F) K.
pneumoniae treated (G) A. baumannii control (H) A. baumannii treated (I) P. aeruginosa treated
(J) P. aeruginosa treated (K) Enterobacter aerogenes control (L) Enterobacter aerogenes
treated
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Results show all control samples contained primarily alive bacteria indicating that samples
used for experiments were good. The bacteria treated with cF2 indicate qualitatively that ESKAPE
bacteria were susceptible to treatment and were inhibited accordingly. Some green bacterial cells
may be noted in images of treated cells as cF2 is anticipated to eliminate 99.99% of bacteria.

9) Bioinformatics
Two main proteins were looked at in ESKAPE bacteria: penicillin-binding-protein, and betalactamase. Two binding sites were found (K. pneumoniae for beta-lactamase and S. aureus for
penicillin-binding-protein) and will be used as a model for binding. Binding affinities are deemed
acceptable if -7.0 kcal/mol or greater. Binding confirmations were simulated with AutoDock Vina.
Enterobacter aerogenes did not have any proteins available from ProteinDataBank and was
analyzed as a result.

A) Enterococcus faecium
6BSQ (Penicillin-binding-protein 4)
Predicted
Binding
Pockets
(CASTp)

A
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Table 36: Bioinformatics diagram of 6BSQ (Penicillin-binding-protein 4) in Enterococcus
faecium (A) Predicted binding pocket of 6BSQ, red signifies predicted binding region (B)
Predicted binding of EGCG-S and protein 6BSQ, pink is EGCG-S green is 6BSQ (C) Enhanced
image of EGCG-S and protein 6BSQ residues, pink is EGCG-S green is 6BSQ (D) 2D diagram
of interaction between 6BSQ and EGCG-S, blue colored regions signify area of binding (E)
Predicted binding affinity of the specified region, number is deemed too low if not greater than 7.0 kcal/mol

The binding affinity of protein 6BSQ found in Enterococcus faecium did not have enough time to
find a proper binding pocket with a binding affinity of -7.0 kcal/mol. Protein 6BSQ contains
bonding interactions such as van der Waals, Conventional Hydrogen Bond, Carbon Hydrogen
Bond, Alkyl, and Pi-Alkyl bonds. Bonds can be found from regions ALA A:173 up to TYR A:401.
While the bond affinity may not be acceptable, it is close to being a good charge. This implies that
the proper bond may be somewhere within this region and should be further look at in future
studies.

B) Acinetobacter baumannii
3UDI (Penicillin-binding-protein1a)
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Table 36: Bioinformatics diagram of 3UDI (Penicillin-binding-protein 1a) in Acinetobacter
baumannii (A) Predicted binding pocket of 3UDI, red signifies predicted binding region (B)
Predicted binding of EGCG-S and protein 3UDI, pink is EGCG-S green is 3UDI (C) Enhanced
image of predicting binding of EGCG-S and protein 3UDI, pink is EGCG-S green is 3UDI (D)
2D diagram of interaction between 6BSQ and EGCG-S, blue colored regions signify area of
binding (E) Predicted binding affinity of the specified region, number is deemed too low if not
greater than -7.0 kcal/mol
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The binding affinity found for Acinetobacter baumannii was not favorable being at a charge of 4.4 kcal/mol. It was found that the region looked at contained an unfavorable donor-donor bond
of SER B: 47. While there may be this undesired bond, there is a Pi-Sigma bond found on TYR
B:155 which is a desirable type of bond that aids in drug to protein binding. This may mean that
the region of interest may be close and just outside of SER B:47 since TYR B:155 is so close to it.
Continuation of this protein will have to be looked at in future studies.

C) Pseudomonas aeruginosa
3OC2 (Penicillin-binding-protein 3)
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Table 36: Bioinformatics diagram of 3OC2 (Penicillin-binding-protein 3) in Pseudomonas
aeruginosa (A) Predicted binding pocket of 3OC2, red signifies predicted binding region (B)
Predicted binding of EGCG-S and protein 3OC2, pink is EGCG-S green is 3OC2 (C) Enhanced
image of EGCG-S protein 3OC2 residues, pink is EGCG-S green is 3OC2 (D) 2D diagram of
interaction between 6BSQ and EGCG-S, blue colored regions signify area of binding (E)
Predicted binding affinity of the specified region, number is deemed too low if not greater than 7.0 kcal/mol
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Results shown show multiple desirable traits such as the Pi-Sigma bond, Pi-Pi-Stacked and Pi-Pi
T-shaped bonds. The Pi-Sigma bond is beneficial for previously mentioned reasons of the drug to
protein affinity. Pi-Pi Stacking is a noncovalent interaction that is an attractive bond between
aromatic rings. While this is a favorable type of bond, it is still a weak covalent bond. A Pi-Pi Tshaped bond is when there is a bond interaction between two aromatic groups that resemble a T
shape. These types of bonds are identical to Pi-Pi Stacked in termed of strength. While there were
no unfavorable bonds found, the binding affinity is still not high enough, only being at -5.7
kcal/mol. Ligand-protein interactions will need to be continued for this protein in future studies.
D) Staphylococcus aureus
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Table 36: Bioinformatics diagram of 1MWT (Penicillin-binding-protein) in Staphylococcus
aureus (A) Predicted binding pocket of 1MWT, red signifies predicted binding region (B)
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Predicted binding of EGCG-S and protein 1MWT, pink is EGCG-S green is 1MWT (C)
Enhanced image predicted binding of EGCG-S and protein 1MWT residues, pink is EGCG-S
green is 1MWT (D) Enhanced image interaction between residues of 1MWT and EGCG-S
shown in Biovia Discovery (E) 2D diagram of interaction between 1MWT and EGCG-S, blue
colored regions signify area of binding (F) Predicted binding affinity of the specified region,
number is deemed too low if not greater than -7.0 kcal/mol

E) Klebsiella pneumoniae
5FAS (Beta-lactamase)
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Table 36: Bioinformatics diagram of 5FAS (Beta-lactamase) in Klebsiella pneumoniae (A)
Predicted binding pocket of 5FAS, red signifies predicted binding region (B) Predicted binding
of EGCG-S and protein 5FAS, pink is EGCG-S green is 5FAS (C) Enhanced image of predicted
binding between EGCG-S and protein 5FAS residues, pink is EGCG-S green is 5FAS (D)
Enhanced image interaction between residues between 5FAS and EGCG-S shown in Biovia
Discovery (E) 2D diagram of interaction between 5FAS and EGCG-S, blue colored regions
signify area of binding (F) Predicted binding affinity of the specified region, number is deemed
too low if not greater than -7.0 kcal/mol
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EGCG-S can bind to both major proteins: beta-lactamase and penicillin-binding-protein
in ESKAPE bacteria. Due to the large size of some of the proteins not all areas were able to be
analyzed entirely. Proteins observed were primarily penicillin-binding-proteins to find any
potential similarities. Staphylococcus aureus and Klebsiella pneumoniae had successful hits with
binding affinities of -7.3 kcal/mol and -7.0 kcal/mol respectively. These can be used as models to
help identify binding regions within other ESKAPE proteins. Staphylococcus aureus used the
protein 1MWT (penicillin-binding-protein 2a) where it was found that EGCG-S binds to 12
positively charge amino acids (LYS A:147, A:148, A:270, A:273 A:289, A:290, A:319, A:322,
B:147 B:148, B:153, B:318,) and 9 negatively charged amino acids (ASP A:275, A:295, A:320,
A:323, A:552; GLU A:294, B:150, B:161 B:239). A few polar molecules, such as asparagine,
also bonded to EGCG-S. Regions for the binding of EGCG-S to 1MWT can be found on the end
of the stearate carbon chains as well as the middle benzenediol. Klebsiella pneumoniae used the
protein 5FAS (beta-lactamase) where EGCG-S was bonded to 6 positively charged amino acids
(HIS B:90; ARG B100, B250; LYS B:208, B:255 and 5 negatively charged amino acids (ASP
A:101, A:229, A:230; glutamic acid B:198, A:227). Protein 5FAS has a Pi-Sigma bond (THR
B:197) which helps with insertion of the polyphenol within the receptors binding site (Arthur,
Uzairu 2019). It can be noted that 1MWT does not have a Pi-Sigma bond within the analyzed
binding site should be looked for in the protein. Multiple interactions can be found within
aromatic groups of both proteins as well. 5FAS has binding sites on EGCG-S identical to that of
1MWT where the benzenediol and the ends of the palmitates have binding sites. Other areas
within these proteins should be analyzed to ensure that there is not a stronger ligand-protein
binding site. The remainder of ESKAPE bacteria should have sequences analyzed to attempt and
find any regions identical to that of 1MWT or 5FAS. Enterobacter aerogenes was not analyzed
due to no sequences or isotopes found of its proteins on ProteinDataBank.
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Conclusion
The data presented shows that the green tea polyphenol, EGCG-S, can inhibit the growth
of potential ESKAPE pathogens. This polyphenol works not only on its own but has been shown
to have synergistic effects with different antibiotics. Formulations cF1 and cF2 have near perfect
inhibition compared to that of EGCG-S on its own. The results suggest that EGCG-S can work as
a preventative as shown in the Congo red biofilm study, but it struggles with preformed biofilms.
Those that had the greatest effect are when the polyphenols were combined with antibiotics. The
in-house formulations cF1 and cF2 had great success, showing an inhibition of 99.99% - 100% on
the bacterial plates. EGCG-S was used at a concentration of 2.5 mg/mL, allowing for future studies
to be conducted with a more concentrated version of the polyphenol to see if this can make a
difference on its overall inhibition.
Since the development of penicillin and other antibiotics, microorganisms have slowly
been developing a resistance to them. Whether by means of excessive drug use, unnecessary
antimicrobial utilization and substandard pharmaceuticals, hospital-acquired infections have been
able to thrive such as the ESKAPE microorganisms. Modern antibiotic treatments have been losing
their potency with each generation of antibiotic resistant bacteria. Even penicillin, the magic bullet,
has lost some of its effectiveness due to penicillin binding protein and beta-lactamase proteins.
This study has shown EGCG-S and formulations cF1 and cF2 can be utilized in combination with
current treatments to help reduce the number of nosocomial infections. As research continues and
further develops, new preservatives and antibiotic alternatives can help circumvent modern
antibiotic resistant bacteria.
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Future Studies
x
x
x
x
x
x
x
x

Test combination effectiveness of cF1 and cF2 with antibiotics for percentage of
inhibition
Perform experiments above with P-EGCG rather than EGCG-S to see efficiency
Perform crystal violet assay with different concentrations of cF1 and cF2 to quantitatively
observe lowest dilution to inhibition ratio
Fluorescence microcopy to observe live dead assay of EGCG-S and cF1 on ESKAPE
bacteria
Determine the phylogenetic relationship of antibiotic resistant products from ESKAPE
bacteria
Observe the effect of EGCG-S and P-EGCG on ESKAPE bacteria via fluorescence
microscopy
Perform a time study for Congo Red Qualitative assay to determine how long treatments
can effectively inhibit the formation of biofilms
Create a crystalized structure of EGCG-S to confirm that conformation is accurate of
bioinformatics work
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